We provide marker retention, lytic and lysogenic phage detection, bacterial viability determination, strain identity testing, purity testing, API 20E identification, and gram staining. Additional testing is available. We also provide extensive sequencing methodology, restriction digest analyses, and Southern and Northern blot testing.
AVANCE IS COMMITTED TO QUALITY
Our industry-leading quality system is designed and maintained to support drug and device research and development, GLP pre-clinical trials, cGMP biomanufacturing, and clinical trials.
Avance Biosciences provides biological testing services to support regulatory submission for clients around the world. These services are conducted under the requirements of Good Laboratory Practices and Current Good Manufacturing Practices as promulgated by the U.S. Food and Drug Administration 21 CFR Part 58 and 21 CFR Part 210 and 211, as well as Good Manufacturing Practice according to ICH Q7, where applicable to the laboratory services provided.